News in the Life Sciences Industry | |
Results 141 - 160 out of 453 displayed. | |
« 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 » |
Immatics Presents Phase I Data from ACTolog® Multi-Target Pilot Study IMA101 at the 35th Annual SITC Conference |
Read more ›› |
By: GlobenewsWire - 10 Nov 2020 |
Related companies: Immatics Biotechnologies GmbH |
BioNTech Announces Third Quarter 2020 Financial Results and Corporate Progress |
Read more ›› |
By: GlobenewsWire - 10 Nov 2020 |
Related companies: BioNTech SE |
Indivumed Launches Groundbreaking AI Platform to Leverage Multi-omics Data for Discoveries in Oncology |
HAMBURG, Germany, Nov. 10, 2020 /PRNewswire/ -- Indivumed announced today the launch of its new, AI-integrated Advanced Data Analytics Platform which will accelerate drug targets and diagnostics discoveries. In the past six months, Indivumed has built an ensemble of cutting-edge technologies... Read more ›› |
By: PR Newswire Association LLC. - 10 Nov 2020 |
Related companies: Indivumed GmbH |
3D-Micromac Unveils High-Throughput Selective Laser Annealing System for Magnetic Sensor Manufacturing |
CHEMNITZ, Germany, Nov. 10, 2020 /PRNewswire/ -- 3D-Micromac AG, the industry leader in laser micromachining and roll-to-roll laser systems for the semiconductor, photovoltaic, medical device and electronics markets, today introduced the first industrial selective laser annealing system for magnetic... Read more ›› |
By: PR Newswire Association LLC. - 10 Nov 2020 |
Abbott Announces the U.S. Launch of the IonicRF(TM) Generator for Use in Patients Living With Chronic Pain |
ABBOTT PARK, Ill., Nov. 10, 2020 /PRNewswire/ -- Abbott (NYSE: ABT) today announced the launch of the IonicRF(TM) Generator - a new device recently cleared by the U.S. Food and Drug Administration to deliver a non-surgical, minimally invasive treatment for the management of pain in the nervous... Read more ›› |
By: PR Newswire Association LLC. - 10 Nov 2020 |
Related companies: Abbott GmbH & Co. KG | Abbott Rapid Diagnostics Germany GmbH | Abbott Medical GmbH |
Activ Surgical Announces Formation of European Advisory Board |
Digital surgery pioneer names prominent medical experts to guide pan-European commercialization efforts Read more ›› |
By: PR Newswire Association LLC. - 10 Nov 2020 |
Insilico announces a multi-target AI-powered drug discovery collaboration with Janssen |
BEIJING, Nov. 10, 2020 /PRNewswire/ -- Insilico Medicine, a leader in deep generative reinforcement learning for target discovery, small molecule generation, and prediction of clinical trial outcomes, today announced that it entered into a multi-target drug discovery agreement with Janssen Pharmaceutica... Read more ›› |
By: PR Newswire Association LLC. - 10 Nov 2020 |
Affimed and Roivant Sciences Announce Licensing and Strategic Collaboration Agreement to Develop and Commercialize Novel Innate Cell Engagers (ICE®) for Multiple Cancer Targets |
Read more ›› |
By: GlobenewsWire - 09 Nov 2020 |
Related companies: Affimed GmbH |
New Preclinical Data being Presented at SITC Underscore Promising Combinations of Affimed’s AFM13 and Cytokine-Activated Natural Killer Cells |
Read more ›› |
By: GlobenewsWire - 09 Nov 2020 |
Related companies: Affimed GmbH |
Chr. Hansen Holding A/S - Manager's transactions |
Read more ›› |
By: GlobenewsWire - 09 Nov 2020 |
Fujirebio Europe and CENTOGENE Enter Partnership to Provide Rapid and High-Quality Preventive SARS-CoV-2 Antigen Testing |
Read more ›› |
By: GlobenewsWire - 09 Nov 2020 |
Related companies: Centogene N.V. |
Termination of Bridge Biotherapeutics's Collaboration and License Agreement with Boehringer Ingelheim |
SEONGNAM, South Korea, Nov. 9, 2020 /PRNewswire/ -- On November 9, 2020, Bridge Biotherapeutics (288330 KQ) reported to the Korea Stock Exchange that the Company and Boehringer Ingelheim have mutually agreed on the termination of the Collaboration and License Agreement entered into in July 2019... Read more ›› |
By: PR Newswire Association LLC. - 09 Nov 2020 |
New Research Study Supports Clinical Utility of Circulating Tumor Cell Count for Metastatic Breast Cancer |
First randomized clinical trial demonstrating that CTC count may help personalize treatment choices Read more ›› |
By: PR Newswire Association LLC. - 09 Nov 2020 |
Merck to Collaborate with Donghao Lansheng to Pilot New Import Policy in China |
SHANGHAI, Nov. 8, 2020 /PRNewswire/ -- On November 6, Merck, a leading science and technology company, announced the signing of a Letter of Intent with Donghao Lansheng... Read more ›› |
By: PR Newswire Association LLC. - 08 Nov 2020 |
Merck and Transcenta Collaborate to Advance Continuous Biomanufacturing, Make the 'Facility of the Future' a Reality |
SHANGHAI, Nov. 8, 2020 /PRNewswire/ -- On November 7, Merck, a leading science and technology company, and Transcenta, a global biotherapeutics company, announced a strategic technology... Read more ›› |
By: PR Newswire Association LLC. - 08 Nov 2020 |
Trading in Novo Nordisk shares by board members, executives and associated persons on 4 and 5 November 2020 |
Read more ›› |
By: GlobenewsWire - 06 Nov 2020 |
XJTLU launches new Academy of Pharmacy |
SUZHOU, China, Nov. 6, 2020 /PRNewswire/ -- On 11 November 2020, Xi'an Jiaotong-Liverpool University will launch its new XJTLU Wisdom Lake Academy of Pharmacy. Read more ›› |
By: PR Newswire Association LLC. - 06 Nov 2020 |
Daewoong Pharmaceutical Announces Publication of Novel P-CAB Fexuprazan Phase 1 Bridging Study |
- Bridging study results, published in the SCI journal, AP&T, demonstrate no racial differences exist in pharmacokinetic and pharmacodynamic properties of fexuprazan Read more ›› |
By: PR Newswire Association LLC. - 06 Nov 2020 |
Johnson & Johnson Innovation Announces Three Strategic Collaborations with a Focus on Advancing Healthcare Solutions in China |
SHANGHAI, Nov. 6, 2020 /PRNewswire/ -- Johnson & Johnson Innovation, division of Johnson & Johnson (China) Investment Limited, announced today three new collaborations with strategic partners in China at the third China International Import Expo (CIIE) in Shanghai. These latest collaborations,... Read more ›› |
By: PR Newswire Association LLC. - 06 Nov 2020 |
UCB Showcases Key Rheumatology Data at American College of Rheumatology Convergence 2020 |
BRUSSELS, Nov. 5, 2020 /PRNewswire/ -- UCB, a global biopharmaceutical company, today announced new data on its TNF inhibitor, CIMZIA(® )(certolizumab pegol), and investigational IL-17A and IL-17F inhibitor, bimekizumab. Data are being presented at the American College of Rheumatology... Read more ›› |
By: PR Newswire Association LLC. - 06 Nov 2020 |
« 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 » |
Upcoming Life Sciences Events
- January 2021
- BioSeed Digital 2021
- NutrEvent
- AgeingFIT
Latest company news
Taconic Biosciences Expands Immuno-oncology Animal Model Portfolio